Prevention of venous thromboembolism in pregnant patients with a history of venous thromboembolic disease: A retrospective cohort study
Thrombosis Research May 10, 2018
Lazo-Langner A, et al. - Researchers attempted to explore the optimal prophylactic strategies in pregnant women with a history of venous thromboembolism (VTE). Subjects were followed until 6 weeks postpartum. Patients with a previous unprovoked event (including antepartum VTE) received antenatal prophylaxis, mostly with low dose low molecular weight heparin (LMWH). Among 199 pregnancies, 147 pregnancies occurred in women with unprovoked or estrogen-related VTE history and 52 pregnancies in women with provoked VTE. Data displayed the low occurrence of ante- and postpartum VTE recurrences in patients with previous VTE due to the use of prophylactic doses of LMWH during pregnancy and puerperium.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries